AiiNTENSE, founded in 2018 and based in France, is at the forefront of integrating AI into healthcare, particularly targeting the specialized fields of neurology and critical care. The company leverages telemedicine to offer personalized patient care while enhancing medical research efficiency. Their approach centers around high-quality health data utilization, crucial for addressing complex medical questions.
Their platform boasts various professional applications, including téléexpertise, téléconsultation, télésuivi, a dynamic dashboard for intensivists, and health data utilization. Such features enrich their data lakes, allowing for a robust and comprehensive healthcare solution.
AiiNTENSE secured a €60.00K Pre Seed Round investment in January 2020 from IMT Starter. This funding underscores early-stage investor confidence in the potential of their platform to innovate within the intersection of AI and healthcare, making it a compelling prospect for further investment.